IMS Health Holdings Inc. and Quintiles Transnational Holdings are merging in an all-stock deal aimed at creating “a leading portfolio of anonymous patient records, technology-enabled data collection, and observational research experts to address critical healthcare issues of cost, value, and patient outcomes.” The new company, to be called Quintiles IMS Holdings, says its combined strength will be to support drug development from inception through demonstrating the value of new medicines. The 2015 combined revenue of …
Read More